A critical understanding of drug mobilities must include analysis of how markets are linked together. The reduced costs for regional and transnational mobility likewise provided structural benefits to the drug trade. Organizations could simply insert themselves into the existing infrastructure, using highways, charting flight paths, purchasing and converting vehicles to transport product. In doing so, they developed intermodal mobilities that relied on various forms of movement to reach desired markets. State interdiction campaigns operated as “mobilities regimes” against traffickers, where the contention between mobility for some and immobility for others, gives rise to a regulatory regime that relies heavily on “big data” to organize individuals according to risk analysis profiles. This paper seeks to put the literature on the drug trade and drug policy in conversation with mobilities studies and transport history, using Mexico’s history as a case study to better understand the linkages across these fields.
See more of: AHA Sessions